+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

From
From
From
From
From
From
From
From
From
From
Genomics Market Overview, 2025-30 - Product Thumbnail Image

Genomics Market Overview, 2025-30

  • Report
  • June 2025
  • 106 Pages
  • Global
From
From
From
U.S. Bispecific Antibodies Market Forecast to 2033 - Product Thumbnail Image

U.S. Bispecific Antibodies Market Forecast to 2033

  • Report
  • October 2025
  • 100 Pages
  • United States
From
From
From
North America Gene Expression Market Report and Forecast 2025-2034 - Product Thumbnail Image

North America Gene Expression Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 250 Pages
  • North America
From
Middle East and Africa Genetic Testing Market Outlook, 2030 - Product Thumbnail Image

Middle East and Africa Genetic Testing Market Outlook, 2030

  • Report
  • November 2025
  • 70 Pages
  • Middle East, Africa
From
Asia-Pacific Genetic Testing Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Genetic Testing Market Outlook, 2030

  • Report
  • November 2025
  • 97 Pages
  • Asia Pacific
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more